Cargando…
Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?
Cystic fibrosis (CF) is caused by a defect in the CF transmembrane regulator that leads to depletion and dehydration of the airway surface liquid (ASL) of the lung epithelium, providing an environment that can be infected by bacteria leading to increased morbidity and mortality. Pseudomonas aerugino...
Autores principales: | Williams, Huw D., Behrends, Volker, Bundy, Jacob G., Ryall, Ben, Zlosnik, James E. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109665/ https://www.ncbi.nlm.nih.gov/pubmed/21687721 http://dx.doi.org/10.3389/fmicb.2010.00120 |
Ejemplares similares
-
Metabolite Profiling to Characterize Disease-related Bacteria: GLUCONATE EXCRETION BY PSEUDOMONAS AERUGINOSA MUTANTS AND CLINICAL ISOLATES FROM CYSTIC FIBROSIS PATIENTS
por: Behrends, Volker, et al.
Publicado: (2013) -
Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2012) -
Hypertonic saline releases the attached small intestinal cystic fibrosis mucus
por: Ermund, Anna, et al.
Publicado: (2015) -
Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021) -
Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients
por: Barboza, Marcelo A.I., et al.
Publicado: (2011)